Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBH vs. RYOIX: which is better?

Bottom line

BBH vs RYOIX: the short answer

BBH (VanEck Biotech ETF) and RYOIX (Biotechnology Fund) share a meaningful slice of their top holdings — about 64% by weight.

But RYOIX is far broader, holding 74 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.

BBH is cheaper at 0.35% vs 1.38% — a difference of $103 a year per $10,000 invested.

Over five years, RYOIX returned +4.0% a year vs +2.7% for BBH.

Updated Nov 19, 2026

BBH vs RYOIX side by side

BBHRYOIX
TypeETFMutual fund
Fund familyVanEckGuggenheim
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%1.38%
Annual cost per $10k$35$138
10-yr cost on $10k (prospectus)$443$1,709
Max front loadNone—
12b-1 fee—0%
1-yr return+21.2%+30.7%
5-yr return (annualized)+2.7%+4.0%
10-yr return (annualized)+4.5%+5.9%
Best quarter+27.6%+28.3%
Worst quarter−18.2%−22.5%
Net assets (fund)$395.6M$136.8M
Number of holdings2574
Portfolio turnover19%75%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBHRYOIXDifference
2025+21.2%+30.7%−9.6%
2024−4.4%−0.7%−3.6%
2023+3.9%+6.1%−2.2%
2022−15.1%−13.1%−2.1%
2021+11.8%+1.8%+10.0%
2020+22.1%+22.1%−0.0%
2019+25.8%+25.0%+0.7%
2018−10.2%−9.0%−1.2%
2017+16.6%+29.7%−13.1%
2016−15.0%−19.5%+4.5%

Source: Fund prospectus bar charts

Holdings overlap

16 of BBH's top 25 holdings also appear in RYOIX's top 25.

Shared top holdings
HoldingBBHRYOIX
Amgen Inc15.25%5.05%
Gilead Sciences Inc12.79%4.49%
Vertex Pharmaceuticals Inc9.10%4.32%
Regeneron Pharmaceuticals Inc6.21%2.93%
Revolution Medicines Inc5.27%2.48%
Argenx SE4.97%1.48%
Natera Inc4.92%2.12%
Alnylam Pharmaceuticals Inc3.83%2.36%
Biogen Inc3.63%2.13%
Moderna Inc3.36%2.15%
Illumina Inc3.17%1.94%
United Therapeutics Corp2.83%1.72%
BeOne Medicines Ltd2.81%2.17%
Insmed Inc2.67%1.79%
Incyte Corp2.49%1.62%

Source: SEC Form N-PORT

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

RYOIX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

FAQ

What is the difference between BBH and RYOIX?
BBH (VanEck Biotech ETF) and RYOIX (Biotechnology Fund) share a meaningful slice of their top holdings — about 64% by weight. But RYOIX is far broader, holding 74 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
Which is cheaper, BBH or RYOIX?
BBH has the lower expense ratio (0.35%).
Should I own both BBH and RYOIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.